Impact of previous high-dose melphalan on CAR-T efficacy in patients with myeloma
Автор: VJHemOnc – Video Journal of Hematology & HemOnc
Загружено: 2025-02-10
Просмотров: 173
Описание:
Noopur Raje, MD, Massachusetts General Hospital, Boston, MA, comments on the impact of high-dose melphalan on outcomes in patients with multiple myeloma receiving BCMA-directed CAR T-cells, highlighting pre-clinical work that demonstrated that previous exposure to high-dose chemotherapy may lead to T-cell exhaustion and senescence. This interview took place at the 66th ASH Annual Meeting and Exposition, held in San Diego, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке:
